317 related articles for article (PubMed ID: 7544646)
1. The receptor tyrosine kinase p185HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia.
Bühring HJ; Sures I; Jallal B; Weiss FU; Busch FW; Ludwig WD; Handgretinger R; Waller HD; Ullrich A
Blood; 1995 Sep; 86(5):1916-23. PubMed ID: 7544646
[TBL] [Abstract][Full Text] [Related]
2. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
Qing X; Qing A; Ji P; French SW; Mason H
Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
[TBL] [Abstract][Full Text] [Related]
3. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
Liu YL; Wang XN; Liu HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Thy-1 (CDw90) expression in CD34+ acute leukemia.
Holden JT; Geller RB; Farhi DC; Holland HK; Stempora LL; Phillips CN; Bray RA
Blood; 1995 Jul; 86(1):60-5. PubMed ID: 7540889
[TBL] [Abstract][Full Text] [Related]
5. Role of C-kit receptor in the diagnosis of leukemia: a relationship between expression of C-kit receptor and that of CD33 in leukemic blasts.
Muroi K; Amemiya Y; Miura Y; Nakamura M; Suda T
Leuk Res; 1993 Aug; 17(8):725-6. PubMed ID: 7689130
[No Abstract] [Full Text] [Related]
6. The generation of immunocompetent dendritic cells from CD34+ acute myeloid or lymphoid leukemia cells.
Tsuchiya T; Hagihara M; Shimakura Y; Ueda Y; Gansuvd B; Munkhbat B; Inoue H; Tazume K; Kato S; Hotta T
Int J Hematol; 2002 Jan; 75(1):55-62. PubMed ID: 11843292
[TBL] [Abstract][Full Text] [Related]
7. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
8. CD117/CD34 expression in leukemic blasts.
Wells SJ; Bray RA; Stempora LL; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
[TBL] [Abstract][Full Text] [Related]
9. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
Guc D; Canpinar H; Kucukaksu C; Kansu E
Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
[TBL] [Abstract][Full Text] [Related]
10. CD7 expression on CD34+ cells from chronic myeloid leukaemia in chronic phase.
Martín-Henao GA; Quiroga R; Sureda A; García J
Am J Hematol; 1999 Jul; 61(3):178-86. PubMed ID: 10398310
[TBL] [Abstract][Full Text] [Related]
11. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
[TBL] [Abstract][Full Text] [Related]
12. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
13. Bilineage T-lymphoblastic/myeloid extramedullary blast crisis in chronic myelogenous leukemia.
Nair IM; Feroze M; Aravindan KP
Indian J Pathol Microbiol; 2016; 59(1):107-9. PubMed ID: 26960653
[TBL] [Abstract][Full Text] [Related]
14. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
15. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis.
Fujie H; Tsuchiya S; Morita S; Itano M; Yambe T; Ohasi Y; Minegishi N; Minegishi M; Satou T; Konno T
Leukemia; 1994 Sep; 8(9):1592-5. PubMed ID: 8090037
[TBL] [Abstract][Full Text] [Related]
16. Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia.
Schmetzer HM; Gerhartz HH
Exp Hematol; 1997 Jun; 25(6):502-8. PubMed ID: 9197328
[TBL] [Abstract][Full Text] [Related]
17. c-Cbl tyrosine phosphorylation and subcellular localization in human primary leukemic cells.
Brizzi MF; Rosso A; Dentelli P; Ferrero D; Lanfrancone L; Pegoraro L
Exp Hematol; 1998 Dec; 26(13):1229-39. PubMed ID: 9845379
[TBL] [Abstract][Full Text] [Related]
18. Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis.
Valent P; Spanblöchl E; Bankl HC; Sperr WR; Marosi C; Pirc-Danoewinata H; Virgolini I; Eichler HG; Agis H; Sillaber C
Blood; 1994 Dec; 84(12):4322-32. PubMed ID: 7527672
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-kit receptor (CD117) and CD34 in leukemic cells.
Muroi K; Nakamura M; Amemiya Y; Suda T; Miura Y
Leuk Lymphoma; 1995 Jan; 16(3-4):297-305. PubMed ID: 7536510
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors.
Shimoda K; Okamura S; Harada N; Ikematsu W; Kondo S; Kawasaki C; Tanaka T; Etou T; Akashi K; Okamura T
Cancer Res; 1992 Jun; 52(11):3052-5. PubMed ID: 1534271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
